GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
73.26
+3.88 (5.59%)
Nov 21, 2024, 1:42 PM EST - Market open
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2023. The number of employees decreased by 100 or -9.09% compared to the previous year.
Employees
1,000
Change (1Y)
-100
Growth (1Y)
-9.09%
Revenue / Employee
$267,228
Profits / Employee
-$83,497
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1,000 | -100 | -9.09% |
| Dec 31, 2022 | 1,100 | -100 | -8.33% |
| Dec 31, 2021 | 1,200 | 328 | 37.61% |
| Dec 31, 2020 | 872 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| National HealthCare | 13,123 |
| Omnicell | 3,650 |
| Azenta | 3,500 |
| NeoGenomics | 2,100 |
| Astrana Health | 1,800 |
| Supernus Pharmaceuticals | 652 |
| Beam Therapeutics | 436 |
| MannKind | 414 |
WGS News
- 2 days ago - GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover - Business Wire
- 3 days ago - GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary - Business Wire
- 13 days ago - New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields - Business Wire
- 16 days ago - GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting - Business Wire
- 20 days ago - Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds - Seeking Alpha
- 21 days ago - GeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium Term - Seeking Alpha
- 22 days ago - GeneDx Holdings Corp. (WGS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidance - Benzinga